期刊文献+

原发性醛固酮增多症的诊治进展 被引量:1

下载PDF
导出
出处 《临床荟萃》 CAS 北大核心 2006年第8期595-598,共4页 Clinical Focus
  • 相关文献

参考文献26

  • 1Mulatero P,Stowasser M,Loh KC,et al.Increased diagnosis of primary aldosteronism,including surgically correctable forms,in centers from five continents[J].J Clin Endocrinol Metab,2004,89(3):1045-1050.
  • 2Young WF Jr.Minireview:primary aldosteronism-changing concepts in diagnosis and treatment[J].Endocrinology,2003,144(6):2208-2213.
  • 3Struthers AD.Aldosterone-induced vasculopathy[J].Molecular and Cellular Endocrinology,2004,217 (1-2):239-241.
  • 4Rossi GP,Di BV,Ganzaroli C,et al.Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism[J].Hypertension,2002,40 (1):23-27.
  • 5Milliez P,Girerd X,Plouin PF,et al.Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism[J].J Am Coll Cardiol,2005,45(8):1243-1248.
  • 6Conn JW.Primary aldosteronism,a new clinical syndrome[J].J Lab Clin Med,1955,45(1):3-17.
  • 7Conn JW,Cohen EL,Rovner DR,et al.Normokalemic primary aldosteronism.A dectable cueable cause of curable "essential hypertension[J].JAMA,1965,193(19):200-206.
  • 8Hiramatsu K,Yamada T,Yukimura K,et al.A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity.Results in hypertensive patients[J].Arch Intern Med,1981,141 (12):1589-1593.
  • 9Gordon RD,Stowasser M,Klemm SA,et al.Primary aldosteronism-some genetic,morphological,and biochemical aspects of subtypes[J].Steroids,1995,60(1):35-41.
  • 10杨建梅,郭晓蕙,董爱梅,田曙光.原发性醛固酮增多症的临床特点[J].临床荟萃,2005,20(24):1381-1384. 被引量:21

二级参考文献11

  • 1刘雪娜,周宪梁,刘亚欣,顾晴,陈改玲,孙晓昕,丰雷,惠汝太.原发性醛固酮增多症合并高血浆肾素活性的临床病例分析[J].中国分子心脏病学杂志,2004,4(4):233-234. 被引量:1
  • 2MULATERO P,STOWASSER M, LOH K C.Increased diagnosis of primary aldosteronism,including surgically correctable forms,in centers from five continents[J]. J Clin Endocrinol Metab,2004,89(3):1045-1050.
  • 3YOUNG W F Jr.Minireview:primary aldosteronism-changing concepts in diagnosis and treatment[J]. Endocrinology,2003,144(6):2208-2213.
  • 4STRUTHERS A D. Aldosterone-induced vasculopathy[J]. Molecular and Cellular Endocrinology,2004,217(1-2):239-241.
  • 5ROSSI G P, DI B V, GANZAROLI C, et al. Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism[J]. Hypertension,2002,40(1):23-27.
  • 6MILLIEZ P,GIRERD X,PLOUIN P F.Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism[J]. J Am Coll Cardiol,2005,45(8):1243-1248.
  • 7STOWASSER M, GORDON R D. Primary aldosteronism-careful investigation is essential and rewarding[J]. Molecular and Cellular Endocrinology,2004,217(1-2):33-39.
  • 8STOWASSER M,GORDON R D,GUNASEKERA T G,et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after ‘non-selective' screening of hypertensive patients[J]. J Hypertens,2003,21(11):2149-2157.
  • 9CONN J W, COHEN E L,ROVNER D R,et al. Normokalemic primary aldosteronism. A detectable cause of curable “essential” hypertension[J]. JAMA,1965,19(193):200-206.
  • 10ROSSI E, REGOLISTI G, NEGRO A, et al. High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives[J]. Am J Hypertens,2002,15(10 Pt 1):896-902.

共引文献20

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部